Patent: 6,800,732
✉ Email this page to a colleague
Summary for Patent: 6,800,732
| Title: | Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| Abstract: | A portable DNA sequence is disclosed which is capable of directing intracellular production of metalloproteinase inhibitors. Vectors containing this portable DNA sequence are also set forth, including the vector pUC9-F5/237P10 (ATCC Accession No. 53003). A recombinant-DNA method for the microbial production of a metalloproteinase inhibitor, which method incorporates at least one of the portable DNA sequences and the vectors disclosed herein. |
| Inventor(s): | Carmichael; David F. (Louisville, CO), Anderson; David C. (Louisville, CO), Stricklin; George P. (Germantown, TN), Welgus; Howard G. (St. Louis, MO) |
| Assignee: | Amgen Inc. (Thousand Oaks, CA) |
| Application Number: | 09/987,357 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,800,732
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2005-02-05 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
